Crossmark

Innovative PEGylated chitosan nanocarriers for co-delivery of doxorubicin and CpG in breast cancer therapy: Preparation, characterization, and immunotherapeutic potential

Crossref DOI link: https://doi.org/10.1007/s12032-025-02714-4

Published Online: 2025-04-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alharthi, Sitah

Alrashidi, Amal Abdullah

Ziora, Zyta

Ebrahimi Shahmabadi, Hasan

Alavi, Seyed Ebrahim
License Information

Text and Data Mining valid from 2025-04-23

Version of Record valid from 2025-04-23
More Information

Article History

Received: 10 January 2025

Accepted: 30 March 2025

First Online: 23 April 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below